Discovery of a covalent FGFR2-selective inhibitor overcoming clinically-acquired resistance mutations
X
Xiaohao Huang
X
Xiansheng Cao
L
Lulu Zheng
R
Ruixiang Luo
Z
Zhenglan Fang
Y
Yongling Liang
Y
Yongjuan Zhu
S
Shiyan Chen
L
Lei Zheng
Z
Zheng Xu
X
Xiaokun Li
G
Guang Liang
L
Lingfeng Chen
Article Details
Journal
Nature Communications
Volume / Issue
Vol. 1, Issue 1
Published
August 03, 2026
ISSN
2041-1723
Publisher
Nature Portfolio
Authors (13)
X
Xiaohao Huang
X
Xiansheng Cao
L
Lulu Zheng
R
Ruixiang Luo
Z
Zhenglan Fang
Y
Yongling Liang
Y
Yongjuan Zhu
S
Shiyan Chen
L
Lei Zheng
Z
Zheng Xu
X
Xiaokun Li
G
Guang Liang
L
Lingfeng Chen
Related Articles from this Journal
Synthesis of adaptive 15N-nitrosyl-Co7 nanocluster for electrocatalytic C–H functionalization
Chao Wu, Xu Zhang et al.
Aug 2026
10.1038/s41467-026-76516-1
Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses
Connor Weidle, Natalie Brunette et al.
Aug 2026
10.1038/s41467-026-76114-1
Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk
Ludmila Prokunina-Olsson, Oscar Florez-Vargas et al.
Aug 2026
10.1038/s41467-026-76157-4
Genome-wide annotation of human multi-nucleotide variants reveals widespread functional differences from single nucleotide variants
Weiwei Jin, Wen Cao et al.
Aug 2026
10.1038/s41467-026-76470-y
Allele-specific chromatin architecture shapes imprinted domains and coordinates a distal enhancer and antisense transcription at the mouse Mest-Copg2 domain
Bongmin Bae, Katherine Gu et al.
Aug 2026
10.1038/s41467-026-76506-3